BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27529216)

  • 21. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.
    Li YM; Xu SC; Li J; Han KQ; Pi HF; Zheng L; Zuo GH; Huang XB; Li HY; Zhao HZ; Yu ZP; Zhou Z; Liang P
    Cell Death Dis; 2013 Oct; 4(10):e831. PubMed ID: 24091674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.
    Kallergi G; Papadaki MA; Politaki E; Mavroudis D; Georgoulias V; Agelaki S
    Breast Cancer Res; 2011 Jun; 13(3):R59. PubMed ID: 21663619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modalities to enumerate circulating tumor cells in the bloodstream for cancer prognosis and to monitor the response to the therapy.
    Romano G
    Drugs Today (Barc); 2017 Sep; 53(9):501-514. PubMed ID: 29238763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
    Hamilton G; Rath B
    Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid epithelial/mesenchymal phenotype(s): The 'fittest' for metastasis?
    Jolly MK; Mani SA; Levine H
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):151-157. PubMed ID: 29997040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial to mesenchymal plasticity: role in cancer progression.
    Raja R; Pandey A; Kumar P
    Front Biosci (Landmark Ed); 2020 Jan; 25(5):838-873. PubMed ID: 31585920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor cells: biology and clinical significance.
    Lin D; Shen L; Luo M; Zhang K; Li J; Yang Q; Zhu F; Zhou D; Zheng S; Chen Y; Zhou J
    Signal Transduct Target Ther; 2021 Nov; 6(1):404. PubMed ID: 34803167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
    Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.
    Chen J; Cao S; Situ B; Zhong J; Hu Y; Li S; Huang J; Xu J; Wu S; Lin J; Zhao Q; Cai Z; Zheng L; Wang Q
    J Exp Clin Cancer Res; 2018 Jun; 37(1):127. PubMed ID: 29954422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer.
    Cierna Z; Mego M; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Cingelova S; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
    BMC Cancer; 2014 Jun; 14():472. PubMed ID: 24972610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic Transitions the Processes Involved in Regulation of Growth and Proangiogenic Properties of Stem Cells, Cancer Stem Cells and Circulating Tumor Cells.
    Kulus M; Farzaneh M; Bryja A; Zehtabi M; Azizidoost S; Abouali Gale Dari M; Golcar-Narenji A; Ziemak H; Chwarzyński M; Piotrowska-Kempisty H; Dzięgiel P; Zabel M; Mozdziak P; Bukowska D; Kempisty B; Antosik P
    Stem Cell Rev Rep; 2024 May; 20(4):967-979. PubMed ID: 38372877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.
    Raimondi C; Gradilone A; Naso G; Vincenzi B; Petracca A; Nicolazzo C; Palazzo A; Saltarelli R; Spremberg F; Cortesi E; Gazzaniga P
    Breast Cancer Res Treat; 2011 Nov; 130(2):449-55. PubMed ID: 21298334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluid Shear Stress Induces EMT of Circulating Tumor Cells via JNK Signaling in Favor of Their Survival during Hematogenous Dissemination.
    Xin Y; Li K; Yang M; Tan Y
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
    Giordano A; Gao H; Anfossi S; Cohen E; Mego M; Lee BN; Tin S; De Laurentiis M; Parker CA; Alvarez RH; Valero V; Ueno NT; De Placido S; Mani SA; Esteva FJ; Cristofanilli M; Reuben JM
    Mol Cancer Ther; 2012 Nov; 11(11):2526-34. PubMed ID: 22973057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.
    Wang H; Stoecklein NH; Lin PP; Gires O
    Oncotarget; 2017 Jan; 8(1):1884-1912. PubMed ID: 27683128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.
    Yu M; Bardia A; Wittner BS; Stott SL; Smas ME; Ting DT; Isakoff SJ; Ciciliano JC; Wells MN; Shah AM; Concannon KF; Donaldson MC; Sequist LV; Brachtel E; Sgroi D; Baselga J; Ramaswamy S; Toner M; Haber DA; Maheswaran S
    Science; 2013 Feb; 339(6119):580-4. PubMed ID: 23372014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
    Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
    Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EMT status of circulating breast cancer cells and impact of fluidic shear stress.
    Jin Y; Cai W; Zhao C; Yang F; Yang C; Zhang X; Zhou Q; Zhao W; Zhang C; Zhang F; Wang M; Li M
    Exp Cell Res; 2022 Dec; 421(1):113385. PubMed ID: 36228736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.